<--- Back to Details
First PageDocument Content
Oncology / Epidemiology / Gynaecological cancer / Cancer / Head and neck cancer / Oral cancer / Metastasis / Skin cancer / Epidemiology of cancer / Medicine / Lymphoma / Otolaryngology
Date: 2013-04-22 06:03:32
Oncology
Epidemiology
Gynaecological cancer
Cancer
Head and neck cancer
Oral cancer
Metastasis
Skin cancer
Epidemiology of cancer
Medicine
Lymphoma
Otolaryngology

Can Surv II-Chapter27.qxp

Add to Reading List

Source URL: survcan.iarc.fr

Download Document from Source Website

File Size: 578,46 KB

Share Document on Facebook

Similar Documents

Cancer / Clinical medicine / Health / Infectious causes of cancer / Papillomavirus / RTT / Gynaecological cancer / Vaccines / Human papillomavirus infection / HPV vaccines / Gardasil / Wart

INTRODUCTION Anogenital human papillomavirus (HPV) infections are nearly ubiquitous among sexually active individuals: data indicate that up to 80% of sexually active persons experience one or more anogenital HPV infect

DocID: 1rtdm - View Document

RTT / Gynaecological cancer / Gynaecology / Ovarian cancer

Elvira Ann Marano August 20, October 27, 2010

DocID: 1rpU4 - View Document

Cancer / RTT / Health / Clinical medicine / Infectious causes of cancer / Papillomavirus / Gynaecological cancer / Carcinogens / Human papillomavirus infection / Cervix / N.E.D. / Ovarian cancer

PDF Document

DocID: 1rmwK - View Document

Medicine / Clinical medicine / Cancer / RTT / Infectious causes of cancer / Cancer screening / Gynaecological cancer / Sexually transmitted diseases and infections / Cervical cancer / Fecal occult blood / Preventive healthcare / HPV vaccines

Be Healthy Wellness Benefits Be Healthy–

DocID: 1rifu - View Document

Cancer / Clinical medicine / Health / Infectious causes of cancer / RTT / Papillomavirus / Gynaecological cancer / Vaccines / Cervical cancer / HPV vaccines / Human papillomavirus infection / Cancer screening

Invited Speaker Seminar Title: Combining decision modeling and epidemiologic studies to determine optimal cervical cancer control policies in the era of HPV vaccines. Speaker: Shalini Kulasingam, PhD Host: Prof David Mat

DocID: 1re0N - View Document